World Osteoporosis Day highlights why bone health matters all life. Learn about osteoporosis risk factors, warning signs, bone density tests and ways to reduce fracture risk.
FDA approves Rhapsido (remibrutinib) as the first treatment specifically for adults with symptomatic dermographism not adequately controlled by H1 antihistamines.